The Lancet Regional Health - Southeast Asia (Mar 2024)

Averting catastrophic tuberculosis costs in an Indian state: integration of Ayushman Bharat Arogya Karnataka with National Tuberculosis Elimination Program

  • Suresh G. Shastri,
  • Pooja Sancheti,
  • Sharath Burugina Nagaraja,
  • Gagana G. Dayananda,
  • Pujari K. Srinivas,
  • Murugesh Jayaprakash,
  • Shivashankara N. Ninge Gowda,
  • Aditi Krishnamurthy,
  • Balu P. Srinivasa,
  • Anil Singarajipura,
  • Randeep Devendiran

Journal volume & issue
Vol. 22
p. 100327

Abstract

Read online

Summary: The WHO's “End TB” initiative aims to reduce catastrophic expenses, incidence, and mortality by 90%, 80%, and 0%, respectively by 2030 and Government of India has committed to reaching these goals by 2025. Despite tremendous progress, tuberculosis (TB) remains one of the main public health issues. To limit TB transmission and expedite reduction in incidence, further measures are needed. These milestones and objectives remain aspirational until we achieve “Universal access” to high-quality TB diagnosis and treatment. The goals of the study include outlining the process of ‘Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana-Arogya Karnataka’ (AB-PMJAY-ArK) integration with the National TB Elimination Program (NTEP) in Karnataka, the types of TB patients who used AB-PMJAY-ArK services, and calculating the cost per TB patient at primary, secondary, and tertiary healthcare facilities, both public and private, stratified by type of service. Increased coverage, elimination of treatment delays, early and free treatment, and prevention of missing patients are benefits of integrating NTEP with Ayushman Bharat-PMJAY.

Keywords